Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
9.50
+0.26 (2.81%)
Aug 27, 2026, 1:34 PM EDT - Market open
Advanced Biomed Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 2.6 | 2.9 | 2.61 | 2.62 | 4.78 | 0.07 |
Cash & Short-Term Investments | 2.61 | 2.9 | 2.61 | 2.62 | 4.78 | 0.07 |
Cash Growth | -49.60% | 11.35% | -0.55% | -45.18% | 7156.86% | - |
Other Receivables | 0.1 | 0.23 | 0.21 | 0.15 | 0.16 | 0 |
Receivables | 0.1 | 0.23 | 0.21 | 0.15 | 0.16 | 0 |
Prepaid Expenses | 1.92 | 2.89 | 0.24 | 0.01 | 0.06 | 0.85 |
Other Current Assets | 5.89 | 0 | - | - | - | - |
Total Current Assets | 10.53 | 6.03 | 3.05 | 2.79 | 5.01 | 0.91 |
Property, Plant & Equipment | 0.12 | 0.4 | 0.65 | 0.95 | 1.23 | 0.09 |
Other Intangible Assets | - | - | 0.12 | 0.25 | 0.41 | - |
Long-Term Deferred Charges | - | - | 0.64 | 0.55 | - | - |
Other Long-Term Assets | 0 | 0.08 | - | 0.06 | 0.07 | - |
Total Assets | 10.65 | 6.51 | 4.46 | 4.6 | 6.71 | 1.01 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.38 | 0.63 | 0.62 | 0.63 | 0.76 | 0 |
Accrued Expenses | 0.34 | 0.03 | 0.08 | 0.09 | 0.1 | 0.02 |
Short-Term Debt | 0.11 | 0.17 | 0.78 | - | - | - |
Current Portion of Long-Term Debt | 0.57 | 0.92 | - | - | - | - |
Current Portion of Leases | 0.02 | 0.04 | 0.06 | 0.22 | 0.24 | 0.01 |
Other Current Liabilities | 0.01 | 1.1 | 1.18 | 2.34 | 1.89 | 0 |
Total Current Liabilities | 1.43 | 2.89 | 2.73 | 3.28 | 2.99 | 0.03 |
Long-Term Debt | - | 0.14 | - | - | - | - |
Long-Term Leases | 0.01 | 0.01 | 0.06 | 0.02 | 0.23 | 0 |
Total Liabilities | 1.44 | 3.03 | 2.8 | 3.29 | 3.22 | 0.03 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 0 | 0.02 | 0.02 | 0.02 | 0.1 | 0.01 |
Additional Paid-In Capital | 21.62 | 21.35 | 16.49 | 13.67 | 12.58 | 6.57 |
Retained Earnings | -13.25 | -19.23 | -15.97 | -13.19 | -9.46 | -5.43 |
Comprehensive Income & Other | 0.84 | 1.34 | 1.12 | 0.8 | 0.27 | -0.18 |
Shareholders' Equity | 9.21 | 3.48 | 1.66 | 1.31 | 3.49 | 0.98 |
Total Liabilities & Equity | 10.65 | 6.51 | 4.46 | 4.6 | 6.71 | 1.01 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.71 | 1.26 | 0.91 | 0.24 | 0.47 | 0.01 |
Net Cash (Debt) | 1.9 | 1.64 | 1.7 | 2.39 | 4.31 | 0.06 |
Net Cash Growth | -39.11% | -3.40% | -28.92% | -44.68% | 7225.84% | - |
Net Cash Per Share | 1.68 | 1.60 | 1.70 | 2.39 | 6.08 | 0.10 |
Filing Date Shares Outstanding | 1.38 | 1.08 | 1 | 1 | 1 | 0.57 |
Total Common Shares Outstanding | 1.38 | 1.08 | 1 | 1 | 0.99 | 0.57 |
Working Capital | 9.1 | 3.14 | 0.32 | -0.49 | 2.02 | 0.89 |
Book Value Per Share | 6.66 | 3.21 | 1.66 | 1.31 | 3.53 | 1.70 |
Tangible Book Value | 9.21 | 3.48 | 1.54 | 1.06 | 3.08 | 0.98 |
Tangible Book Value Per Share | 6.66 | 3.21 | 1.54 | 1.06 | 3.11 | 1.70 |
Machinery | 1.05 | 1.69 | 1.55 | 1.51 | 1.38 | 0.84 |
Leasehold Improvements | - | 0.2 | 0.2 | 0.2 | 0.21 | - |